Skip to content
Company Analysis

Concord Medical Services Holdin CCM

A comprehensive view of key metrics, scores, and financial health for Concord Medical Services Holdin

Overview of Concord Medical Services Holdings Limited

CCM NYQ
Healthcare Medical Care Facilities Framework: General Corporate Micro Cap
Concord Medical Services Holdings Limited (CCM), is a Micro Cap company, in the Medical Care Facilities industry, last closed at $3.59, about 405.3% undervalued vs fair value, -35.5% 1Y return, ranked 974/1145 in sector.
Metrics Rev Growth 19.9% ROE 4.2% Gross Margin 5.6%
USD 3.59
0.56%
(Delayed)
• Vol 90d: 94.0%
52-Week Range
Market Cap
$15.60M
Enterprise Value
$1.08B
Overall Score
View breakdown
Overall
Growth
Good
Profitability
Weak
Health
Weak
Efficiency
Fair
Valuation
Weak
Growth
Good
Profitability
Weak
Health
Weak
Efficiency
Fair
Valuation
Weak
Completeness: 88%
Confidence: 92%
Updated: Oct 31
Top Beats

Quick Facts

Website https://www.concordmedical.com
HQ Beijing
Employees 595
Fiscal year Dec 31

Next Events

No upcoming events available.

Fair Value Snapshot

Bear Base Bull
$15
$18
$22
Current: $3.59 +405% vs base

Engine Room Money Flow™

Micro Cap

Corporate Free Cash Flow - Where revenue goes and how value is created

Flow Steps
Revenue
CNY 460.5M
19.9%%
Gross Profit
CNY 25.8M
132.6%%
Operating Income
-CNY 261.5M
50.9%%
Net Income
-CNY 92.8M
69.9%%
Money Flow Bridge
Flow Direction: Money moves from left to right
Components: Breakdown shows composition of each stage
Industry-Specific: Corporate Free Cash Flow

Quality & Reliability Indicators

Cash Conversion Ratio FY2025
315.9%

Operating Cash Flow / Net Income

FCF / Net Income - not meaningful while net income is negative (a near-100% ratio here only reflects cash burn tracking accounting losses, not earnings quality)

Locked Metric
-
Premium
Locked Metric
-
Premium

Where It Leaks

Cash Flow Health critical
Significant cash flow inefficiencies identified. Multiple high-impact leaks require attention.
2
Active Leaks
1/2
Improving
0
High Impact
2
Critical
Locked Leak
Upgrade to view details
Premium
Moat Analysis Corporate Default

Competitive Advantage Assessment

Evaluating Concord Medical Services Holdin's durable competitive advantages across 6 defense dimensions

Overall Moat Strength
17
/100
Weak
Scores based on quantitative metrics and qualitative factors
Full moat analysis

Key strengths

  • Operating Leverage in Effect Operating leverage is evident (score 0.86), with margins expanding over time.

Key risks

  • Commodity Pressure / Weak Differentiation Gross margin at 3.9th percentile with high volatility suggests weak pricing power or commoditized products.
  • Elevated Debt Risk Debt serviceability is weak (score 0.25), raising refinancing risk.

The dashed ring is the peer median. Defense scores are percentile ranks against peers, so 50 is roughly the typical company in this group.

Upgrade to unlock the signals and evidence behind each defense.

Premium access

Unlock full defense analysis

Get key signals, strengths, and risks for every moat dimension.

Upgrade to Premium Unlock all moat defenses and evidence.

Pricing Power

Weak
6
Premium

Signals, strengths and risks for Pricing Power

Premium

Signals, strengths and risks for Cost Advantage

Premium

Signals, strengths and risks for Customer Stickiness

Premium

Signals, strengths and risks for Capital Efficiency

Premium

Signals, strengths and risks for Resilience

Premium

Signals, strengths and risks for Scale & Market Position

Trade-Off Ledger™

Where management spends the performance budget - Growth, Profitability, or Safety

vs Industry Peers 80% Coverage
Trade-Off Triangle Visualization A ternary plot showing CCM's balance between Growth (53.7%), Profitability (17.7%), and Safety (28.6%). Growth 54% Safety 29% Profitability 18%

Click axes to expand details. Marker shows current allocation.

3-Year Trend Analysis Locked
Upgrade to unlock the full 3-year trend analysis and deltas.

Growth

56th percentile vs peers
56
Key Signals
Rev Growth YoY 19.9% 82p Revenue CAGR 3Y -0.8% 36p EPS Growth YoY -3.6% 42p
Strengths
  • Rev Growth YoY in top 20% of peers (19.9%, 82th percentile)
  • Debt/FCF Ratio in top 20% of peers (-11.82, 94th percentile)
Risks

No significant risks identified for this axis.

Profitability

18th percentile vs peers
19
Key Signals
Strengths
Risks
Premium
Unlock full Profitability drilldowns

See the signal-level drivers and insights behind this axis. Upgrade to reveal the full Trade-Off Ledger.

Upgrade Now

Safety

29th percentile vs peers
30
Key Signals
Strengths
Safety drilldowns are available to premium members.

Two Futures

Scenario-based fair value ranges for Concord Medical Services Holdin.

Loading valuation model...
Unable to Compute Fair Value

This company cannot be valued using standard models.

What this means: The Scenario Theatre requires financial data (revenue, cash flow, shares outstanding) to calculate fair value estimates. This data may be unavailable for:

  • Recently listed companies (IPOs, SPACs)
  • Shell companies or holding companies
  • Companies that haven't filed recent financials
  • Foreign companies with limited data coverage
X.X%
X%XX%
X.X%
-XX%XX%
XX.X%
-XX%XX%
Adjust the sliders above to explore different valuation scenarios.
Unlock Premium
Reveal the full Scenario Theatre
See live sliders, narratives, and full Bear/Base/Bull outcomes.
Upgrade Now
Bear
-
- - -
- upside
-
Base
$18.14
- - -
+405.3% vs current
Snapshot base estimate
Bull
-
- - -
- upside
-
Fair Value Range Current: $-
$- $- $-
Actions & Info
Send Feedback
Please select a category.
0/1000